跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,605 条关于
“GNP+”
全部
2,605
临床试验
1,432
药物
493
机构
12
资讯
668
去年
Elraglusib Plus Chemotherapy Shows Promise in Metastatic Pancreatic Cancer
前天
FDA Grants Breakthrough Therapy Designation to Daraxonrasib Plus Chemotherapy in First-Line Metastatic Pancreatic Cancer
去年
Elraglusib Receives EMA Orphan Drug Designation for Pancreatic Cancer Treatment
去年
Actuate Therapeutics' Elraglusib Shows Promise in Pancreatic Cancer as IPO Lock-up Expires
去年
Toripalimab Plus Chemotherapy Shows Promise in Advanced Pancreatic Cancer
去年
Black Swan Graphene Partners with Ferro South Africa to Expand Graphene Technology Distribution
去年
Tempus Validates PurIST Algorithm for Personalized Pancreatic Cancer Treatment Selection in Largest Real-World Study
去年
Actuate Therapeutics Reports Significant Survival Improvement in Metastatic Pancreatic Cancer Phase 2 Trial
9个月前
Phanes Therapeutics to Present First Clinical Data for Spevatamig in Metastatic Pancreatic Cancer at ASCO GI 2026
3个月前
Immuneering Doses First Patient in Phase III MAPKeeper 301 Trial of Atebimetinib Plus Modified Gemcitabine/Nab-Paclitaxel in Metastatic Pancreatic Cancer
第 1 页,共 67 页
上一页
下一页